This Edinburgh company runs international drug trials to test new cancer therapies. It has about 25 customers, mostly small biotech companies based in North America, although it opened offices in Germany and Belgium this year. Sales growth has been boosted by an increase in consultancy work and the company’s growing ability to support larger trials. Chief executive Clare Wareing founded the firm in 1999 with a redundancy payout of £10,000. Sales rose 44% a year from £2.4m in 2006 to £7.2m in 2009.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2010
Rank68
CompanyNexus Oncology
ActivityClinical researcher
LocationEdinburgh
Average 3 year sales growth43.71%
Latest sales £000s7,165
Staff96
Founded1999
Websitewww.nexusoncology.com

If applicable:

* supplied by company † annualised figure